Drug class

Fat Absorption Decreasing Agents

Fat absorption decreasing agents are a formulary and compendial classification of antiobesity medications, principally represented by gastric and pancreatic lipase inhibitors such as orlistat. Read more about Fat Absorption Decreasing Agents

4 drugs in this class 3 manufacturers

Advertisement

Drugs in Fat Absorption Decreasing Agents

Showing 1–4 of 4 drugs

XENICAL (orlistat)

FAT ABSORPTION DECREASING AGENTS · WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER)
H2 PHARMA LLC

ALLI (orlistat)

FAT ABSORPTION DECREASING AGENTS · WEIGHT LOSS MANAGEMENT FOR OVERWEIGHT OR OBESE PATIENT (BODY MASS INDEX 27 OR GREATER)
GSK/Haleon

ORLISTAT

FAT ABSORPTION DECREASING AGENTS · WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER)
H2 PHARMA LLC

ALLI (orlistat)

FAT ABSORPTION DECREASING AGENTS · WEIGHT LOSS MANAGEMENT FOR OVERWEIGHT OR OBESE PATIENT (BODY MASS INDEX 27 OR GREATER)
GSK/Haleon US
Filter & compare in the drug finder → Opens the drug finder with Fat Absorption Decreasing Agents preselected. Add indication or manufacturer filters there.

About Fat Absorption Decreasing Agents.

Fat absorption decreasing agents are a formulary and compendial classification of antiobesity medications, principally represented by gastric and pancreatic lipase inhibitors such as orlistat.

These agents exert their therapeutic effect locally within the gastrointestinal tract by reversibly inhibiting digestive lipases, preventing the hydrolysis of dietary triglycerides into absorbable free fatty acids and monoglycerides.

By blocking the intestinal absorption of roughly thirty percent of ingested fat, they promote calorie deficit and are utilized as adjunct therapy to lifestyle modifications for chronic weight management in overweight and obese individuals.